HCC (hepato cellular carcinoma ) patient survey

Have you been diagnosed with HCC and are currently on oral systemic therapy drug treatment for liver cancer (for example, sorafenib, regorafenib, nivolumab, lenvatinib, pembrolizumab, or cabozantinib)? If so, we’d like to ask for your help. We’d like your feedback on a survey we’re helping to create. If you’d like to get involved, please email [e-mail]. Thank you.